Breast Cancer - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Tailored Treatment for Breast Cancer
(Posted: 05/23/2006, Updated: 10/22/2010) - In this trial, doctors will use a test called the Oncotype DX Breast Cancer Assay, which measures the activity of a set of genes in breast tumor tissue, to determine which women will receive adjuvant chemotherapy in addition to hormone therapy.
- Adjuvant Breast Cancer Therapy for Premenopausal Women
(Posted: 10/11/2005, Updated: 04/08/2010) - In this trial, researchers will study three treatment groups of premenopausal women with endocrine-responsive breast cancer to see which treatment regimen provides the greatest benefits for this population.
- Adjuvant Bisphosphonates for Breast Cancer
(Posted: 07/25/2006, Updated: 02/09/2010) - Drugs called bisphosphonates may be able to prevent bone metastases in women with early breast cancer. With this trial, researchers are comparing a bisphosphonate called clodronate with two newer, more-potent bisphosphonates--zoledronate and ibandronate--in women with stage I-III breast cancer.
- Adjuvant Bevacizumab and Chemotherapy for High-risk Breast Cancer
(Posted: 01/26/2010) - In this trial, patients with lymph node-positive or high-risk, lymph node-negative breast cancer who have received radiation therapy or plan to do so following chemotherapy will be treated with adjuvant chemotherapy and randomly assigned to receive short-term treatment with bevacizumab, long-term treatment with bevacizumab, or an intravenous placebo.
- Targeting HER2 in the Treatment of Ductal Carcinoma in Situ
(Posted: 10/06/2009) - In this clinical trial, women with HER2-positive DCIS will be treated with lumpectomy followed by whole-breast radiation therapy; half of the women will also receive two doses of trastuzumab during their radiation treatment.